Dr. Eric W. Rudnick, MD

Dr. Rudnick practices at West Boca Medical Center in Boca Raton, Florida, part of Tenet Healthcare.

Dr. Rudnick's NPI, 1790171353, was assigned on April 10, 2015. Dr. Rudnick graduated from University of South Florida College of Medicine in 2015. Dr. Rudnick holds Florida license ME139044.

Dr. Rudnick's primary practice is West Boca Medical Center, at 21644 State Rd 7, Boca Raton, FL 33428 in Palm Beach County. The practice phone is (561) 488-8100.

Dr. Rudnick's primary practice is West Boca Medical Center in Boca Raton, Florida, part of Tenet Healthcare. The medical group on file is Dazzling Dermatology. Dmand AI also links Dr. Rudnick to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rudnick practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Rudnick's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Rudnick is licensed in Florida.

CMS data shows 10,652 Medicare services from Dr. Rudnick across 29 procedure codes in 2024, for 549 Medicare patients. Medicare paid $670,217 for them. Every service was in an office.

CMS counts 549 Medicare patients who saw Dr. Rudnick in 2024. The largest group is 65 to 74, with 222 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rudnick's median patient age at 63, with 36% women.

In 2024, Dr. Rudnick wrote 868 Medicare Part D claims for 311 patients. 97% of them were for generic drugs. CMS names the drug for 760 of them, across 17 drugs with 11 or more claims each, at $103,091 in total drug cost. In 2023, CMS named 528 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Rudnick for performance year 2024, reported individually. Dr. Rudnick accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,069 procedures of removal of skin lesions by Dr. Rudnick, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 18 papers to Dr. Rudnick, published from 2014 to 2022. 2020 was the busiest year, with 5. The most frequent topics are Cicatrix, Rituximab and Skin Neoplasms. Dr. Rudnick has published most often in JAAD Case Rep. Dr. Rudnick's most frequent co-authors are Kiran Motaparthi, MD, Colton B. Nielson, MD and Jane Escolas Harrell, MD.

CMS Open Payments shows 21 general payments to Dr. Rudnick from 7 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $201.

Dr. Rudnick graduated from University of South Florida College of Medicine in 2015.